Conditions: Adult T-Cell Leukemia-Lymphoma
Keywords: Lenalidomide ATL ATLL
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 26
Healthy volunteers: no

Brief summary:
To evaluate the efficacy of lenalidomide in patients with Adult T-cell Leukemia-lymphoma (ATL) who have previously received chemotherapy for ATL.

Detailed description:

Arms:
arm 1: Lenalidomide 25mg by mouth (PO) daily until progressive disease or unacceptable toxicity

Interventions: intervention 1: Lenalidomide
Intervention descriptions: intervention 1: 25 mg of Lenalidomide administered orally once daily

Protocol document: